Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

BYETTA 5 MCG DOSE PEN INJ

exenatide
$681.2630per ML

Strength

250 ug/mL

Manufacturer

AstraZeneca Pharmaceuticals LP

NDC

00310651201

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

2/19/2025

Active Ingredients

EXENATIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021773

On Market Since

12/10/2014

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+3.1%

5Y

+9.5%

All

+76.4%

Generic Alternatives

Save up to 50%

1 alternative • Same active ingredient

BYETTA 10 MCG DOSE PEN INJ
Brand
00310652401•AstraZeneca Pharmaceuticals LP
$340.1014
Save 50%

Related Drugs

Same classification

RYBELSUS 3 MG TABLET
Brand
00169430330•Novo Nordisk
$33.1602
per EA
RYBELSUS 14 MG TABLET
Brand
00169431430•Novo Nordisk
$33.1671
per EA
RYBELSUS 7 MG TABLET
Brand
00169430730•Novo Nordisk
$33.1730
per EA
SOLIQUA 100 UNIT-33 MCG/ML PEN
Brand
00024576105•Sanofi-Aventis U.S. LLC
$57.0731
per ML
XULTOPHY 100 UNIT-3.6 MG/ML PEN
Brand
00169291115•Novo Nordisk
$85.8558
per ML
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1538
per ML
VICTOZA 2-PAK 18 MG/3 ML PEN
Brand
00169406012•Novo Nordisk
$87.7373
per ML
VICTOZA 3-PAK 18 MG/3 ML PEN
Brand
00169406013•Novo Nordisk
$87.8351
per ML
OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN
Brand
00169477212•Novo Nordisk
$331.9569
per ML
OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN
Brand
00169413013•Novo Nordisk
$331.9930
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy